- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Biotechnology
- Sub-Industry: Medical-Biomedical/Gene
Chelsea Therapeutics International Ltd+ Add to Watchlist
CHTP:US1.8400 USD 0.0600 3.16%
As of 20:10:00 ET on 05/24/2013.
Company Profile for Chelsea Therapeutics International Ltd (CHTP)
Chelsea Therapeutics International Ltd. is a biopharmaceutical company developing a pipeline of low toxicity antifolate compounds engineered to have anti-inflammatory and anti-tumor activity. The Company's lead candidate is in development as a metabolically inert treatment alternative to Methotrexate for rheumatoid arthritis, psoriasis, and other disorders.
Chelsea Therapeutics International Ltd
Key Executives for Chelsea Therapeutics International Ltd (CHTP)
|Joseph G OlivetoInterim CEO||William D SchwietermanVP/Chief Medical Officer|
|L Arthur HewittVP/Chief Scientific Officer||J Nick RiehleVP:Administration/CFO|
|Michael J RobertsVP:Business Development|